GST-omega genes interact with environmental tobacco smoke on adult level of lung function

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  de Jong, Kim ^a   Boezen, H Marike ^a   Hacken, Nick H T ten ^a   Postma, Dirkje S ^a   Vonk, Judith M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Environmental tobacco smoke; Genes; Lung function

Indexed keywords

GLUTATHIONE TRANSFERASE OMEGA; TOBACCO SMOKE; TRANSFERASE; UNCLASSIFIED DRUG; GLUTATHIONE TRANSFERASE;

ADULT; ADULTHOOD; AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT; CROSS-SECTIONAL STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LUNG FUNCTION; MALE; NUCLEOTIDE SEQUENCE; OCCUPATIONAL EXPOSURE; PRENATAL EXPOSURE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; WORKPLACE; ADOLESCENT; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION; GENETICS; LUNG FUNCTION TEST; MIDDLE AGED; NETHERLANDS; PASSIVE SMOKING; PREGNANCY; PREVALENCE; RISK FACTOR; STATISTICS; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE; RESPIRATORY FUNCTION TESTS; RISK FACTORS; TOBACCO SMOKE POLLUTION; YOUNG ADULT;

EID: 84881178044     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-83     Document Type: Article

References (33)

1. Hospers JJ, Schouten JP, Weiss ST, Postma DS, Rijcken B. Eosinophilia is associated with increased all-cause mortality after a follow-up of 30 years in a general population sample. Epidemiology 2000, 11:261-268. 10.1097/00001648-200005000-00006, 10784241.
2. Knuiman MW, James AL, Divitini ML, Ryan G, Bartholomew HC, Musk AW. Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. Ann Epidemiol 1999, 9:297-306.
3. Doruk S, Ozyurt H, Inonu H, Erkorkmaz U, Saylan O, Seyfikli Z. Oxidative status in the lungs associated with tobacco smoke exposure. Clin Chem Lab Med 2011, 49:2007-2012.
4. Lodrup Carlsen KC, Jaakkola JJ, Nafstad P, Carlsen KH. In utero exposure to cigarette smoking influences lung function at birth. Eur Respir J 1997, 10:1774-1779. 10.1183/09031936.97.10081774, 9272918.
5. Stick SM, Burton PR, Gurrin L, Sly PD, LeSouf PN. Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants. Lancet 1996, 348:1060-1064. 10.1016/S0140-6736(96)04446-7, 8874457.
6. Eisner M. Environmental tobacco smoke exposure and pulmonary function among adults in NHANES III: impact on the general population and adults with current asthma. Environ Health Perspect 2002, 110:765-770. 10.1289/ehp.02110765, 1240946, 12153756.
7. Janson C, Chinn S, Jarvis D, Zock J, Torén K, Burney P. Effect of passive smoking on respiratory symptoms, bronchial responsiveness, lung function, and total serum IgE in the European Community Respiratory Health Survey: a cross-sectional study. Lancet 2001, 358:2103-2109. 10.1016/S0140-6736(01)07214-2, 11784622.
8. Leuenberger P, Schwartz J, Ackermann Liebrich U, Blaser K, Bolognini G, Bongard JP, Brandli O, Braun P, Bron C, Brutsche M. Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. Am J Respir Crit Care Med 1994, 150:1222-1228. 10.1164/ajrccm.150.5.7952544, 7952544.
9. Simoni M, Baldacci S, Puntoni R, Pistelli F, Farchi S, Lo Presti E, Pistelli R, Corbo G, Agabiti N, Basso S, Matteelli G, Di Pede F, Carrozzi L, Forastiere F, Viegi G. Respiratory symptoms/diseases and environmental tobacco smoke (ETS) in never smoker Italian women. Respir Med 2007, 101:531-538. 10.1016/j.rmed.2006.06.021, 16893638.
10. Eisner M, Balmes J, Katz P, Trupin L, Yelin E, Blanc P. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health 2005, 4:7-7. 10.1186/1476-069X-4-7, 1145187, 15890079.
11. Yin P, Jiang CQ, Cheng KK, Lam TH, Lam KH, Miller MR, Zhang WS, Thomas GN, Adab P. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet 2007, 370:751-757. 10.1016/S0140-6736(07)61378-6, 17765524.
12. Wilk JB, Walter RE, Laramie JM, Gottlieb DJ, O'Connor GT. Framingham Heart Study genome-wide association: results for pulmonary function measures. BMC Med Genet 2007, 8(1):8. 1821008, 17335567.
13. Eaton DL, Bammler TK. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci 1999, 49:156-164. 10.1093/toxsci/49.2.156, 10416260.
14. Hayes JD, Flanagan JU, Jowsey IR. Glutathione Transferases. Annu Rev Pharmacol Toxicol 2005, 45:51-88. 10.1146/annurev.pharmtox.45.120403.095857, 15822171.
15. Kabesch M, Hoefler C, Carr D, Leupold W, Weiland SK, von Mutius E. Glutathione S transferase deficiency and passive smoking increase childhood asthma. Thorax 2004, 59:569-573. 10.1136/thx.2003.016667, 1747082, 15223862.
16. Schultz EN, Devadason SG, Khoo SK, Zhang G, Bizzintino JA, Martin AC, Goldblatt J, Laing IA, Le Souef PN, Hayden CM. The role of GSTP1 polymorphisms and tobacco smoke exposure in children with acute asthma. J Asthma 2010, 47:1049-1056.
17. Breton CV, Vora H, Salam MT, Islam T, Wenten M, Gauderman WJ, Van Den Berg D, Berhane K, Peters JM, Gilliland FD. Variation in the GST mu Locus and tobacco smoke exposure as determinants of childhood lung function. Am J Respir Crit Care Med 2009, 179:601-607. 10.1164/rccm.200809-1384OC, 2720124, 19151192.
18. Board PG, Coggan M, Chelvanayagam G, Easteal S, Jermiin LS, Schulte GK, Danley DE, Hoth LR, Griffor MC, Kamath AV, Rosner MH, Chrunyk BA, Perregaux DE, Gabel CA, Geoghegan KF, Pandit J. Identification, characterization, and crystal structure of the omega class glutathione transferases. J Biol Chem 2000, 275:24798-24806. 10.1074/jbc.M001706200, 10783391.
19. Board PG. The omega-class glutathione transferases: structure, function, and genetics. Drug Metab Rev 2011, 43:226-235. 10.3109/03602532.2011.561353, 21495794.
20. Whitbread AK, Tetlow N, Eyre HJ, Sutherland GR, Board PG. Characterization of the human Omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics 2003, 13:131-144. 10.1097/00008571-200303000-00003, 12618591.
21. Laliberte RE, Perregaux DG, Hoth LR, Rosner PJ, Jordan CK, Peese KM, Eggler JF, Dombroski MA, Geoghegan KF, Gabel CA. Glutathione S-Transferase Omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1β posttranslational processing. J Biol Chem 2003, 278:16567-16578. 10.1074/jbc.M211596200, 12624100.
22. Pauwels NS, Bracke KR, Dupont LL, Van Pottelberge GR, Provoost S, Vanden Berghe T, Vandenabeele P, Lambrecht BN, Joos GF, Brusselle GG. Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD. Eur Respir J 2011, 38:1019-1028. 10.1183/09031936.00158110, 21622588.
23. Levy H, Murphy A, Zou F, Gerard C, Klanderman B, Schuemann B, Lazarus R, Garca KC, Celedn J, Drumm M, Dahmer M, Quasney M, Schneck K, Reske M, Knowles M, Pier G, Lange C, Weiss S. IL1B polymorphisms modulate cystic fibrosis lung disease. Pediatr Pulmonol 2009, 44:580-593. 10.1002/ppul.21026, 3716579, 19431193.
24. Harju TH, Peltoniemi MJ, Rytila PH, Soini Y, Salmenkivi KM, Board PG, Ruddock LW, Kinnula VL. Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients. Respir Res 2007, 8:48. 10.1186/1465-9921-8-48, 1939846, 17617905.
25. Yanbaeva DG, Wouters EF, Dentener MA, Spruit MA, Reynaert NL. Association of glutathione-S-transferase omega haplotypes with susceptibility to chronic obstructive pulmonary disease. Free Radic Res 2009, 43:738-743. 10.1080/10715760903038440, 19513904.
26. Stolk R, Rosmalen JGM, Postma D, de Boer R, Navis G, Slaets JPJ, Ormel J, Wolffenbuttel BHR. Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study. Eur J Epidemiol 2008, 23:67-74. 10.1007/s10654-007-9204-4, 18075776.
27. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 1995, 57:289-300.
28. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993, 16:5-40.
29. Gilliland FD, Berhane K, McConnell R, Gauderman WJ, Vora H, Rappaport EB, Avol E, Peters JM. Maternal smoking during pregnancy, environmental tobacco smoke exposure and childhood lung function. Thorax 2000, 55:271-276. 10.1136/thorax.55.4.271, 1745733, 10722765.
30. Coiro V, Volpi R, Stella A, Cataldo S, Giumelli C, Maccanelli F, Araldi A, Chiodera P. Naloxone decreases the inhibitory effect of somatostatin on GH release induced by cigarette smoking in man. J Neural Transm 2011, 118:1173-1175. 10.1007/s00702-011-0610-0, 21360300.
31. Beyea JA, Olson DM, Harvey S. Growth hormone (GH) action in the developing lung: changes in lung proteins after adenoviral GH overexpression. Dev Dyn 2005, 234:404-412. 10.1002/dvdy.20538, 16127721.
32. Allen M, Zou F, Chai H, Younkin C, Miles R, Nair A, Crook J, Pankratz VS, Carrasquillo M, Rowley C, Nguyen T, Ma L, Malphrus K, Bisceglio G, Ortolaza A, Palusak R, Middha S, Maharjan S, Georgescu C, Schultz D, Rakhshan F, Kolbert C, Jen J, Sando S, Aasly J, Barcikowska M, Uitti R, Wszolek Z, Ross O, Petersen R, Graff Radford N, Dickson D, Younkin S, Ertekin-Taner N. Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications. Mol neurodegener 2012, 7:13-13. 10.1186/1750-1326-7-13, 3393625, 22494505.
33. Olivieri M, Poli A, Zuccaro P, Ferrari M, Lampronti G, de Marco R, Lo Cascio V, Pacifici R. Tobacco smoke exposure and serum cotinine in a random sample of adults living in Verona, Italy. Arch Environ Health 2002, 57:355-359. 10.1080/00039890209601421, 12530604.